AMBER LOPEZ: Open Payments
NPI 1154674430 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,760 in 105 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $860 · 2025 $1,760
Food & beverage: $1,760
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $387 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $248 |
| Madrigal Pharmaceuticals | 8 | $197 |
| Phathom Pharmaceuticals, Inc. | 18 | $176 |
| Ardelyx, Inc. | 7 | $167 |
| Aimmune Therapeutics, Inc. | 6 | $155 |
| Celltrion USA Inc. | 6 | $121 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| Lilly USA, LLC | 2 | $45 |
| Amgen Inc. | 3 | $43 |
Products named: RINVOQ, REZDIFFRA, VOQUEZNA, ENTYVIO, IBSRELA, ZENPEP, VEGZELMA, DUPIXENT.
Industry payments across TN — which companies pay providers there.
